Article Text

Download PDFPDF
Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma
  1. Eun Jung Jung, MD*,
  2. Jung Mi Byun, MD, PhD*,,
  3. Young Nam Kim, MD, PhD*,,
  4. Kyung Bok Lee, MD, PhD*,,
  5. Moon Su Sung, MD, PhD*,,
  6. Ki Tae Kim, MD, PhD*, and
  7. Dae Hoon Jeong, MD, PhD*,
  1. * Department of Obstetrics and Gynecology, and
  2. Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, South Korea.
  1. Address correspondence and reprint requests to Dae Hoon Jeong, MD, PhD, Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, 633–165 Gaegeum-dong Busanjin-gu, Busan, South Korea, 614–735. E.mail: obgynjeong{at}


Objective We aimed to analyze the differences in prognosis and the pattern of recurrence between squamous cell carcinoma (SCC) and adenocarcinoma (ADC) in patients with cervical cancer.

Methods We retrospectively reviewed the medical records of 969 patients with SCC and 144 patients with ADC who underwent radical hysterectomy and pelvic lymph node dissection at the Busan Paik Hospital between January 1988 and December 2010.

Results Adenocarcinoma was associated with poorer disease-free survival (P = 0.0515) and overall survival (OS) (P = 0.0156) compared with SCC, and that this was more apparent for patients with International Federation of Gynecology and Obstetrics stages IIA to IIB disease. Subgroup analysis by prognostic factors for recurrence showed significant differences in the OS in the intermediate-risk subgroup (P = 0.0266), but not in the high-risk subgroup (P = 0.1674). Based on the metastatic pattern in patients with recurrence, ADC was associated with an increased risk for distant recurrence resulting from hematogenous spread compared with SCC (P < 0.0001), and patients with distant recurrence showed a worse OS (P = 0.0481) and survival after recurrence (P = 0.0016) than patients with locoregional or lymphatic recurrence. Multivariate analysis showed that ADC was a significant independent factor for poor disease-free survival (P = 0.0034) and OS (P = 0.0001).

Conclusions Adenocarcinoma is associated with a poorer prognosis and a greater probability of distanat recurrence compared with SCC. Different therapeutic strategies for ADC need to be developed, and when considering the greater tendency for distant recurrence in patients with ADC, systemic chemotherapy may have a role in reducing the risk of hematogenous spread.

  • Cervical adenocarcinoma
  • Prognosis
  • Metastatic pattern
  • Recurrent cervical cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interests.